Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2007

View Archived Issues

Novel recombinant poxvirus vaccine candidates immunogenic against HIV antigens in mice

HuMAb 17C7: a new monoclonal antibody against rabies

Novel anticancer compounds reported in recent patent literature

Tasquinimod enhances response to androgen ablation in prostate cancer models

GlaxoSmithKline reports on novel compounds with in vitro activity against human papilloma virus

Recent Tokai University and Sankyo patent covers new therapeutic agents for renal disorders

Novel VLA-1 antagonists presented at the recent ACS meeting

New treatment options for gastrointestinal disorders disclosed in recent patent literature

Enrollment progresses in phase III study of Rencarex

Vicinium studied in phase II for locally persistent noninvasive bladder cancer

SuperGen completes sale of remaining Nipent rights

Lilly withdraws E.U. marketing authorization application for Arxxant

Wyeth brings to 100% its ownership stake in Wyeth K.K. Japan

Surface Logix closes second tranche of Series D financing

Acomplia approved in Switzerland

Taxus Express2 paclitaxel-eluting coronary stent system approved in Japan

Proellex improves symptoms associated with uterine fibroids

Final median survival data from phase II GVAX prostate cancer study

Glycopyrrolate begins pivotal safety study in pediatric drooling

LX-201 begins pivotal trials

Femathina studied for endometrial thinning in new phase II trial

MB-07803 begins proof-of-concept study in type 2 diabetes

Roche to acquire Bioveris

Basiliximab studied for ulcerative colitis in phase IIb trial

Ceflatonin studied in new phase II/III study in CML

FDA approves new coated Niaspan tablet

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...